Bluejay Diagnostics (BJDX) Other Operating Expenses (2020 - 2024)

Bluejay Diagnostics has disclosed Other Operating Expenses across 5 years of filings, most recently posting $816.0 for Q4 2024.

• Other Operating Expenses for Q4 2024 came in at $816.0, up 18.78% year-over-year; the trailing twelve-month figure through Sep 2025 was $816.0 (down 90.01% YoY), and the FY2024 annual result was $8297.0, down 97.07% from the prior year.
• Other Operating Expenses came in at $816.0 for Q4 2024 at Bluejay Diagnostics, up from $753.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $1.3 million in Q3 2022 to a low of -$2.7 million in Q2 2023.
• The 5-year median for Other Operating Expenses is $34849.0 (2020), against an average of $62343.7.
• Peak annual rise in Other Operating Expenses reached 2092.38% in 2023, while the deepest fall reached 3478.96% in 2023.
• Bluejay Diagnostics' Other Operating Expenses stood at $19448.0 in 2020, then surged by 413.99% to $99961.0 in 2021, then soared by 862.26% to $961888.0 in 2022, then tumbled by 99.93% to $687.0 in 2023, then rose by 18.78% to $816.0 in 2024.
• The last three Other Operating Expenses figures came in at $816.0 (Q4 2024), $753.0 (Q3 2024), and $305.0 (Q2 2024), per Business Quant data.